β1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury

Oncogene

Volumn 25, Issue 9, 2006, Pages 1378-1390

  Cordes, N ^a,b   Seidler, J ^a   Durzok, R ^a   Geinitz, H ^c   Brakebusch, C ^d  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Bundeswehr Institute of Radiobiology   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

1 integrin; Akt; ECM; Ionizing radiation; p130Cas; PI3K

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BETA1 INTEGRIN; BETA1A INTEGRIN; BETA1B INTEGRIN; COLLAGEN TYPE 3; FIBRONECTIN; GROWTH FACTOR; IMMUNOGLOBULIN G; PAXILLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; POLYLYSINE; PROTEIN DERIVATIVE; PROTEIN KINASE B; PROTEIN P130; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; WORTMANNIN; GROWTH PROMOTOR; SCLEROPROTEIN;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GENE SILENCING; GENOTOXICITY; GLIOMA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION DOSE; RADIATION INJURY; SIGNAL TRANSDUCTION; TUMOR CELL; X RAY; BRAIN TUMOR; CELL ADHESION; CELL CULTURE; CULTURE TECHNIQUE; FIBROBLAST; GLIOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALIA;

ANTIGENS, CD29; BRAIN NEOPLASMS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL SURVIVAL; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; FIBRONECTINS; GLIOMA; GROWTH SUBSTANCES; HUMANS; MICE; PROTO-ONCOGENE PROTEINS C-AKT; RADIATION INJURIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; X-RAYS;

EID: 33644778551     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209164     Document Type: Article

References (47)

1. Almeida EA, Hie D, Han Q, Hauck CR, Jin F, Kawakatsu H et al. (2000). J Cell Biol 149: 741-754.
2. Armulik A, Svineng G, Wennerberg K, Fässler R, Johansson S. (2000). Exp Cell Res 254: 55-63.
3. Armulik A. (2002). Front Biosci 7: d219-d227.
4. Barcellos-Hoff MH. (2001). J Mammary Gland Biol Neoplasia 6: 213-221.
5. Beinke C, van Beuningen D, Cordes N. (2003). Int J Radiat Biol 79: 721-731.
6. Brakebusch C, Fässler R. (2003). EMBO J 22: 2324-2333.
7. Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB. (2004). Semin Radiat Oncol 14: 259-266.
8. Cordes N. (2004). Cancer Res 64: 5683-5692.
9. Cordes N, van Beuningen D. (2003). Brit J Cancer 88: 1470-1479.
10. Cordes N, Hansmeier B, Beinke C, Meineke V, van Beuningen D. (2003). Brit J Cancer 89: 2122-2132.
11. Cordes N, Meineke V. (2003). Strahlenther Onkol 179: 337-344.
12. Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. (1999). Blood 93: 1658-1667.
13. Dedhar S, Hannigan GE. (1997). Curr Opin Cell Biol 8: 657-669.
14. Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. (2003). Oncogene 22: 5885-5896.
15. Elbashir SM, Harborth J, Weber K, Tuchl T. (2002). Methods 26: 199-213.
16. Fässler R, Pfaff M, Murphy J, Noegel AA, Johansson S, Timpl R et al. (1995). J Cell Biol 128: 979-988.
17. Fornaro M, Steger CA, Bennett AM, Wu JJ, Languino LR. (2000). Mol Biol Cell 11: 2235-2249.
18. Giancotti FG, Ruoslahti E. (1999). Science 285: 1028-1032.
19. Hanks SK, Polte TR. (1997). Bioessays 19: 137-145.
20. Hanks SK, Ryzhova L, Shin NY, Brabek J. (2003). Front Biosci 8: d982-d996.
21. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J et al. (1996). Nature 379: 91-96.
22. Hynes RO. (2002). Cell 110: 673-687.
23. Kasahara T, Koguchi E, Funakoshi M, Aizu-Yokota E, Sonoda Y. (2002). Antioxid Redox Signal 4: 491-499.
24. Khwaja A, Rodriguez-Viciana P, Wennström S, Warne HP, Downward J. (1997). EMBO J 16: 2783-2793.
25. Kinbara K, Goldfinger LE, Hansen M, Chou FL, Ginsberg MH. (2003). Nat Rev Mol Cell Biol 4: 767-776.
26. King WG, Mattaliano MD, Chan TO, Tsichlis PN, Brugge JS. (1997). Mol Cell Biol 17: 4406-4418.
27. Martin SS, Vuori K. (2004). Biochim Biophys Acta 1692: 145-157.
28. Oguey D, George PW, Ruegg C. (2000). Gene Ther 7: 1292-1303.
29. Owen JD, Ruest PJ, Fry DW, Hanks SK. (1999). Mol Cell Biol 19: 4806-4818.
30. Park CC, Bissell MJ, Barcellos-Hoff MH. (2000). Mol Med Today 6: 324-329.
31. Parsons JT. (2003). J Cell Sci 116: 1409-1416.
32. Pfaff M, Liu S, Erle DJ, Ginsberg MH. (1998). J Biol Chem 273: 6104-6109.
33. Sakai T, Zhang Q, Fässler R, Mosher DF. (1998). J Cell Biol 141: 527-538.
34. Schaller MD, Hildebrand JD, Parsons JT. (1999). Mol Biol Cell 10: 3489-3505.
35. Schaller MD. (2001). Biochem Biophys Acta 1540: 1-21.
36. Schwartz MA. (1997). J Cell Biol 139: 575-578.
37. Schwartz MA, Assoian RK. (2001). J Cell Sci 114: 2553-2560.
38. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C et al. (1999). Nat Med 5: 662-668.
39. Shen Y, Schaller MD. (1999). Mol Biol Cell 10: 2507-2518.
40. Shimaoka M, Takagi J, Springer TA. (2002). Annu Rev Biophys Biomol Struct 31: 485-516.
41. Tadokoro S, Shattil SJ, Eto K, Tai V, Liddington RC, de Pereda JM et al. (2003). Science 302: 103-106.
42. Unger M, Weaver VM. (2003). Methods Mol Biol 223: 315-347.
43. Veiling T, Nilsson S, Stefansson A, Johansson S. (2004). EMBO Rep 5: 901-905.
44. Vlodavsky I, Lui GM, Gospodarowicz D. (1980). Cell 19: 607-616.
45. Watt FM. (2002). EMBO J 21: 19-26.
46. Wennerberg K, Armulik A, Sakai T, Karlsson M, Fassler R, Schaefer EM et al. (2000). Mol Cell Biol 20: 5758-5765.
47. Yamada KM, Even-Ram S. (2002). Nat Cell Biol 4: E75-E76.